Clinicians' attitude on mass drug administration under the program to eliminate lymphatic filariasis: a qualitative study from Orissa, India.
Identifieur interne : 003016 ( PubMed/Corpus ); précédent : 003015; suivant : 003017Clinicians' attitude on mass drug administration under the program to eliminate lymphatic filariasis: a qualitative study from Orissa, India.
Auteurs : Anna Salomi Kerketta ; Bontha Veerraju BabuSource :
- Asia-Pacific journal of public health [ 1010-5395 ] ; 2009.
English descriptors
- KwdEn :
- Communicable Disease Control (organization & administration), Community Health Centers, Diethylcarbamazine (administration & dosage), Elephantiasis, Filarial (prevention & control), Filaricides (administration & dosage), Health Care Surveys, Humans, India, Information Dissemination, Middle Aged, Practice Patterns, Physicians', Private Practice.
- MESH :
- chemical , administration & dosage : Diethylcarbamazine, Filaricides.
- geographic : India.
- organization & administration : Communicable Disease Control.
- prevention & control : Elephantiasis, Filarial.
- Community Health Centers, Health Care Surveys, Humans, Information Dissemination, Middle Aged, Practice Patterns, Physicians', Private Practice.
Abstract
The global program to eliminate lymphatic filariasis (LF) is currently based on mass drug administration (MDA) with annual single dose of antifilarials. In India, the MDA is implemented by primary health centers (PHC) of the district health system. The aim of the present study was to explore the attitudes of clinicians working at PHC level in three districts of Orissa, India. The data are obtained from interviews of 50 clinicians (35 from PHCs and 15 private). Only 11 PHC clinicians and 1 private clinician opined that the elimination of LF is possible through MDA of diethylcarbamazine (DEC); and 40% PHC and 87% private clinicians strongly felt that the elimination is not feasible through MDA and that the yearly single dose of DEC was not efficacious. The remaining clinicians were unable to comment on the feasibility and efficacy of MDA. The indifferent attitudes arise from lack of knowledge or erroneous beliefs. A good understanding of the program through reorientation and rigorous training should be emphasized to make the MDA successful.
DOI: 10.1177/1010539508327032
PubMed: 19124342
Links to Exploration step
pubmed:19124342Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Clinicians' attitude on mass drug administration under the program to eliminate lymphatic filariasis: a qualitative study from Orissa, India.</title><author><name sortKey="Kerketta, Anna Salomi" sort="Kerketta, Anna Salomi" uniqKey="Kerketta A" first="Anna Salomi" last="Kerketta">Anna Salomi Kerketta</name><affiliation><nlm:affiliation>Regional Medical Research Centre, Indian Council of Medical Research, Bhubaneswar, Orissa, India.</nlm:affiliation></affiliation></author><author><name sortKey="Babu, Bontha Veerraju" sort="Babu, Bontha Veerraju" uniqKey="Babu B" first="Bontha Veerraju" last="Babu">Bontha Veerraju Babu</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2009">2009</date><idno type="RBID">pubmed:19124342</idno><idno type="pmid">19124342</idno><idno type="doi">10.1177/1010539508327032</idno><idno type="wicri:Area/PubMed/Corpus">003016</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">003016</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Clinicians' attitude on mass drug administration under the program to eliminate lymphatic filariasis: a qualitative study from Orissa, India.</title><author><name sortKey="Kerketta, Anna Salomi" sort="Kerketta, Anna Salomi" uniqKey="Kerketta A" first="Anna Salomi" last="Kerketta">Anna Salomi Kerketta</name><affiliation><nlm:affiliation>Regional Medical Research Centre, Indian Council of Medical Research, Bhubaneswar, Orissa, India.</nlm:affiliation></affiliation></author><author><name sortKey="Babu, Bontha Veerraju" sort="Babu, Bontha Veerraju" uniqKey="Babu B" first="Bontha Veerraju" last="Babu">Bontha Veerraju Babu</name></author></analytic><series><title level="j">Asia-Pacific journal of public health</title><idno type="ISSN">1010-5395</idno><imprint><date when="2009" type="published">2009</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Communicable Disease Control (organization & administration)</term><term>Community Health Centers</term><term>Diethylcarbamazine (administration & dosage)</term><term>Elephantiasis, Filarial (prevention & control)</term><term>Filaricides (administration & dosage)</term><term>Health Care Surveys</term><term>Humans</term><term>India</term><term>Information Dissemination</term><term>Middle Aged</term><term>Practice Patterns, Physicians'</term><term>Private Practice</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Diethylcarbamazine</term><term>Filaricides</term></keywords><keywords scheme="MESH" type="geographic" xml:lang="en"><term>India</term></keywords><keywords scheme="MESH" qualifier="organization & administration" xml:lang="en"><term>Communicable Disease Control</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Elephantiasis, Filarial</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Community Health Centers</term><term>Health Care Surveys</term><term>Humans</term><term>Information Dissemination</term><term>Middle Aged</term><term>Practice Patterns, Physicians'</term><term>Private Practice</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The global program to eliminate lymphatic filariasis (LF) is currently based on mass drug administration (MDA) with annual single dose of antifilarials. In India, the MDA is implemented by primary health centers (PHC) of the district health system. The aim of the present study was to explore the attitudes of clinicians working at PHC level in three districts of Orissa, India. The data are obtained from interviews of 50 clinicians (35 from PHCs and 15 private). Only 11 PHC clinicians and 1 private clinician opined that the elimination of LF is possible through MDA of diethylcarbamazine (DEC); and 40% PHC and 87% private clinicians strongly felt that the elimination is not feasible through MDA and that the yearly single dose of DEC was not efficacious. The remaining clinicians were unable to comment on the feasibility and efficacy of MDA. The indifferent attitudes arise from lack of knowledge or erroneous beliefs. A good understanding of the program through reorientation and rigorous training should be emphasized to make the MDA successful.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">19124342</PMID><DateCreated><Year>2009</Year><Month>01</Month><Day>06</Day></DateCreated><DateCompleted><Year>2009</Year><Month>03</Month><Day>18</Day></DateCompleted><DateRevised><Year>2016</Year><Month>10</Month><Day>20</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">1010-5395</ISSN><JournalIssue CitedMedium="Print"><Volume>21</Volume><Issue>1</Issue><PubDate><Year>2009</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Asia-Pacific journal of public health</Title><ISOAbbreviation>Asia Pac J Public Health</ISOAbbreviation></Journal><ArticleTitle>Clinicians' attitude on mass drug administration under the program to eliminate lymphatic filariasis: a qualitative study from Orissa, India.</ArticleTitle><Pagination><MedlinePgn>112-7</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/1010539508327032</ELocationID><Abstract><AbstractText>The global program to eliminate lymphatic filariasis (LF) is currently based on mass drug administration (MDA) with annual single dose of antifilarials. In India, the MDA is implemented by primary health centers (PHC) of the district health system. The aim of the present study was to explore the attitudes of clinicians working at PHC level in three districts of Orissa, India. The data are obtained from interviews of 50 clinicians (35 from PHCs and 15 private). Only 11 PHC clinicians and 1 private clinician opined that the elimination of LF is possible through MDA of diethylcarbamazine (DEC); and 40% PHC and 87% private clinicians strongly felt that the elimination is not feasible through MDA and that the yearly single dose of DEC was not efficacious. The remaining clinicians were unable to comment on the feasibility and efficacy of MDA. The indifferent attitudes arise from lack of knowledge or erroneous beliefs. A good understanding of the program through reorientation and rigorous training should be emphasized to make the MDA successful.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kerketta</LastName><ForeName>Anna Salomi</ForeName><Initials>AS</Initials><AffiliationInfo><Affiliation>Regional Medical Research Centre, Indian Council of Medical Research, Bhubaneswar, Orissa, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Babu</LastName><ForeName>Bontha Veerraju</ForeName><Initials>BV</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>China</Country><MedlineTA>Asia Pac J Public Health</MedlineTA><NlmUniqueID>8708538</NlmUniqueID><ISSNLinking>1010-5395</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005369">Filaricides</NameOfSubstance></Chemical><Chemical><RegistryNumber>V867Q8X3ZD</RegistryNumber><NameOfSubstance UI="D004049">Diethylcarbamazine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D003140" MajorTopicYN="N">Communicable Disease Control</DescriptorName><QualifierName UI="Q000458" MajorTopicYN="N">organization & administration</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003151" MajorTopicYN="N">Community Health Centers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004049" MajorTopicYN="N">Diethylcarbamazine</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004605" MajorTopicYN="N">Elephantiasis, Filarial</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005369" MajorTopicYN="N">Filaricides</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019538" MajorTopicYN="N">Health Care Surveys</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007194" MajorTopicYN="N" Type="Geographic">India</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D033181" MajorTopicYN="Y">Information Dissemination</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010818" MajorTopicYN="Y">Practice Patterns, Physicians'</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011331" MajorTopicYN="N">Private Practice</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2009</Year><Month>1</Month><Day>7</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2009</Year><Month>1</Month><Day>7</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2009</Year><Month>3</Month><Day>19</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">19124342</ArticleId><ArticleId IdType="pii">21/1/112</ArticleId><ArticleId IdType="doi">10.1177/1010539508327032</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003016 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 003016 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= PubMed
|étape= Corpus
|type= RBID
|clé= pubmed:19124342
|texte= Clinicians' attitude on mass drug administration under the program to eliminate lymphatic filariasis: a qualitative study from Orissa, India.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:19124342" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |